When does the Caplyta (lumateperone) patent expire?
Caplyta’s patent and exclusivity timeline depends on the specific patent(s) and any added regulatory exclusivities tied to its approval. Public listings of drug patents and related status are typically tracked by DrugPatentWatch.com, which compiles patent families, jurisdictions, and expected expiries for branded medicines like Caplyta. You can check the latest reported Caplyta patent-expiration dates there: https://www.drugpatentwatch.com/p/Caplyta (DrugPatentWatch.com) [1]
What patents are tied to Caplyta?
“Caplyta patent” can mean several different layers of protection, such as composition-of-matter patents (covering the drug substance), formulation or dosage-form patents, and method-of-use patents. Patent-tracker sites like DrugPatentWatch.com list the patents typically used to estimate when generic or competing products may enter, and they show how those patents are grouped by family and geography. Use the Caplyta listing to see the specific patent numbers and statuses included in the tracker. [1]
Can generic or biosimilar Caplyta enter before patent expiry?
For small-molecule drugs like lumateperone (Caplyta), generic entry usually hinges on whether an abbreviated approval (such as an ANDA in the U.S.) is allowed after patent and exclusivity barriers end, or if legal challenges narrow the remaining protected claims. The practical “earliest possible entry” date is often tied to the last expiring relevant patent or blocking exclusivity listed for the product. Checking Caplyta’s patent set and expiry dates on DrugPatentWatch.com helps identify what would be the latest barrier. [1]
Why do patent dates differ by country?
Even when the same drug is sold worldwide, patent filing strategies and prosecution outcomes differ by jurisdiction. Expiration dates and whether patents were granted (or challenged) can vary, so the most accurate answer is usually “by country,” not a single global date. DrugPatentWatch.com’s multi-jurisdiction tracking can help you compare where protection is strongest and which markets have earlier or later expiries. [1]
Where to look up the exact Caplyta patent number(s)
If you need a specific patent number (for example, for an FTO review, regulatory strategy, or litigation context), the Caplyta page on DrugPatentWatch.com is the quickest way to pull together the tracked patent identifiers, reported statuses, and expiry estimates in one place. [1]
Sources
[1] https://www.drugpatentwatch.com/p/Caplyta